ResearcherShanghai Jiao Tong UniversityNo recent work listed
Xinyu Huang
Matched on ORCID iD 0000-0002-4802-1172; OpenAlex author ID A5102764101. Sources: OpenAlex.
Their work
- Papers
- 14 (first author 0, last author 8)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 24
2012: 1 paper · 2013: none · 2014: 3 papers · 2015: 2 papers · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 2 papers
Papers 14
- hENT1's role in adjuvant intra-arterial gemcitabine-based chemotherapy for resectable pancreatic cancer patients. Last author DOI 10.1186/s12876-023-02666-x↗
- CircATP13A1 (hsa_circ_0000919) promotes cell proliferation and metastasis and inhibits cell apoptosis in pancreatic ductal adenocarcinoma via the miR-186/miR-3… Last author PMID 38058810↗
- Jumonji-C domain-containing protein 5 suppresses proliferation and aerobic glycolysis in pancreatic cancer cells in a c-Myc-dependent manner. Last author DOI 10.1016/j.cellsig.2022.110282↗
- Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study. Last author DOI 10.1038/s41598-020-64068-3↗
- Combined Exosomal GPC1, CD82, and Serum CA19-9 as Multiplex Targets: A Specific, Sensitive, and Reproducible Detection Panel for the Diagnosis of Pancreatic Ca… Co-author DOI 10.1158/1541-7786.mcr-19-0588↗
- Gambogic acid induces autophagy and combines synergistically with chloroquine to suppress pancreatic cancer by increasing the accumulation of reactive oxygen s… Last author DOI 10.1186/s12935-018-0705-x↗
- Localized Controlled Delivery of Gemcitabine via Microsol Electrospun Fibers to Prevent Pancreatic Cancer Recurrence. Co-author DOI 10.1002/adhm.201800593↗
- Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2). Last author DOI 10.1186/s13046-017-0579-0↗
- Novel blood-based microRNA biomarkers for diagnosis of pancreatic cancer: a meta-analysis. Last author DOI 10.5301/tj.5000240↗
- Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation. Last author PMID 26175941↗
- H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Co-author DOI 10.1007/s13277-014-2185-5↗
- SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9. Co-author DOI 10.1007/s13277-014-2598-1↗
- miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1. Co-author DOI 10.1186/1756-9966-33-54↗
- Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via β-adrenergic receptor-dependent activation of P38/MAPK pathway. Co-author DOI 10.5754/hge11476↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hongcheng Wang · 8 shared papers, 2012–2023 · strength 0.86
- Paper CircATP13A1 (hsa_circ_0000919) promotes cell proliferation and metastasis and inhibits cell apoptosis in pancreatic duc… PMID 38058810↗
- Paper Jumonji-C domain-containing protein 5 suppresses proliferation and aerobic glycolysis in pancreatic cancer cells in a c… DOI 10.1016/j.cellsig.2022.110282↗
- Paper Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective… DOI 10.1038/s41598-020-64068-3↗
- Guanggai Xia · 6 shared papers, 2017–2022 · strength 0.68
- Paper Jumonji-C domain-containing protein 5 suppresses proliferation and aerobic glycolysis in pancreatic cancer cells in a c… DOI 10.1016/j.cellsig.2022.110282↗
- Paper Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective… DOI 10.1038/s41598-020-64068-3↗
- Paper Combined Exosomal GPC1, CD82, and Serum CA19-9 as Multiplex Targets: A Specific, Sensitive, and Reproducible Detection … DOI 10.1158/1541-7786.mcr-19-0588↗
- Zhou Yuan · 6 shared papers, 2014–2023 · strength 0.45
- Paper CircATP13A1 (hsa_circ_0000919) promotes cell proliferation and metastasis and inhibits cell apoptosis in pancreatic duc… PMID 38058810↗
- Paper Novel blood-based microRNA biomarkers for diagnosis of pancreatic cancer: a meta-analysis. DOI 10.5301/tj.5000240↗
- Paper Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation. PMID 26175941↗
- Jiazhe Liu · 2 shared papers, 2020–2022 · strength 0.32
- Paper Jumonji-C domain-containing protein 5 suppresses proliferation and aerobic glycolysis in pancreatic cancer cells in a c… DOI 10.1016/j.cellsig.2022.110282↗
- Paper Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective… DOI 10.1038/s41598-020-64068-3↗
- Xiu−Yan Huang · 3 shared papers, 2017–2020 · strength 0.31
- Paper Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective… DOI 10.1038/s41598-020-64068-3↗
- Paper Gambogic acid induces autophagy and combines synergistically with chloroquine to suppress pancreatic cancer by increasi… DOI 10.1186/s12935-018-0705-x↗
- Paper Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reducta… DOI 10.1186/s13046-017-0579-0↗
- Chen Jin · 1 shared paper, 2023 · strength 0.22
- Hengchao Li · 1 shared paper, 2023 · strength 0.22
- Xinzhe Yu · 1 shared paper, 2023 · strength 0.22
- Wei Wang · 1 shared paper, 2023 · strength 0.22
- Xiongzhi Wangpu · 1 shared paper, 2023 · strength 0.20
- Qingcai Meng · 3 shared papers, 2015–2017 · strength 0.19
- Paper Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reducta… DOI 10.1186/s13046-017-0579-0↗
- Paper Novel blood-based microRNA biomarkers for diagnosis of pancreatic cancer: a meta-analysis. DOI 10.5301/tj.5000240↗
- Paper Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation. PMID 26175941↗
- Yiwei Wang · 1 shared paper, 2022 · strength 0.19
- Kate Nong · 3 shared papers, 2014 · strength 0.13
- Paper H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. DOI 10.1007/s13277-014-2185-5↗
- Paper SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9. DOI 10.1007/s13277-014-2598-1↗
- Paper miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patche… DOI 10.1186/1756-9966-33-54↗
- Kaixing Ai · 3 shared papers, 2014 · strength 0.13
- Paper H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. DOI 10.1007/s13277-014-2185-5↗
- Paper SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9. DOI 10.1007/s13277-014-2598-1↗
- Paper miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patche… DOI 10.1186/1756-9966-33-54↗
- Chenchao Ma · 3 shared papers, 2014 · strength 0.13
- Paper H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. DOI 10.1007/s13277-014-2185-5↗
- Paper SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9. DOI 10.1007/s13277-014-2598-1↗
- Paper miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patche… DOI 10.1186/1756-9966-33-54↗
- Dong Xiao · 1 shared paper, 2020 · strength 0.10
- Hong Xu · 1 shared paper, 2020 · strength 0.10
- Bo Wu · 2 shared papers, 2014 · strength 0.08
- Hongcheng Wang · 1 shared paper, 2018 · strength 0.08
- Hélder A. Santos · 1 shared paper, 2018 · strength 0.08
- Hongbo Zhang · 1 shared paper, 2018 · strength 0.08
- Wenguo Cui · 1 shared paper, 2018 · strength 0.08
- Jian Jun Huang · 1 shared paper, 2012 · strength 0.04
- Qi Zheng · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.